These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29517945)

  • 1. Management of Ocular Cicatricial Pemphigoid with Intravenous Immunoglobulin Monotherapy.
    Ma L; You C; Hernandez M; Maleki A; Lasave A; Schmidt A; Stephenson A; Zhao T; Anesi S; Foster CS
    Ocul Immunol Inflamm; 2019; 27(4):636-642. PubMed ID: 29517945
    [No Abstract]   [Full Text] [Related]  

  • 2. Rituximab in the treatment of ocular cicatricial pemphigoid: a retrospective cohort study.
    You C; Lamba N; Lasave AF; Ma L; Diaz MH; Foster CS
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1221-1228. PubMed ID: 28154932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid: a preliminary report.
    Foster CS; Chang PY; Ahmed AR
    Ophthalmology; 2010 May; 117(5):861-9. PubMed ID: 20045562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies.
    Letko E; Miserocchi E; Daoud YJ; Christen W; Foster CS; Ahmed AR
    Clin Immunol; 2004 Jun; 111(3):303-10. PubMed ID: 15183151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin therapy in patients with ocular-cicatricial pemphigoid: a long-term follow-up.
    Sami N; Letko E; Androudi S; Daoud Y; Foster CS; Ahmed AR
    Ophthalmology; 2004 Jul; 111(7):1380-2. PubMed ID: 15234140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of intravenous immunoglobulin therapy on serum levels of anti-beta 4 antibodies in ocular cicatricial pemphigoid. A correlation with disease activity. A preliminary study.
    Letko E; Bhol K; Foster SC; Ahmed RA
    Curr Eye Res; 2000 Aug; 21(2):646-54. PubMed ID: 11148601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Use of Rituximab and Intravenous Immunoglobulin for Severe Autoimmune Cicatricial Conjunctivitis-An Interventional Case Series.
    Steger B; Madhusudan S; Kaye SB; Stylianides A; Romano V; Maqsood SE; Harper J; Ahmad S
    Cornea; 2016 Dec; 35(12):1611-1614. PubMed ID: 27661067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ocular Cicatricial Pemphigoid - a Retrospective Study].
    Szabó E; Palos M; Skalická P
    Cesk Slov Oftalmol; 2016 Feb; 72(1):283-92. PubMed ID: 27041284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab as an Adjuvant Rescue Treatment for Ocular Cicatricial Pemphigoid.
    Bevans SL; Parker J; Ivey JM; Pavlidakey P; Sami N
    Cornea; 2021 Nov; 40(11):1440-1444. PubMed ID: 33591038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atopy in Patients With Ocular Cicatricial Pemphigoid.
    Ebrahimiadib N; Hernandez M; Modjtahedi BS; Roohipoor CR; Foster CS
    Cornea; 2018 Apr; 37(4):436-441. PubMed ID: 29341971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term remission of ocular cicatricial pemphigoid off immunomodulatory therapy.
    You C; Ma L; Anesi SD; Stephen Foster C
    Eur J Ophthalmol; 2018 Mar; 28(2):157-162. PubMed ID: 29077176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative Management and Long-Term Outcomes in Ocular Cicatricial Pemphigoid Patients Undergoing Cataract Surgery.
    He Y; Quan Z; Zhang R; Ji Z; Jia J; Liu H; Zhang C; He B; Ren Y; Feng Y
    Oxid Med Cell Longev; 2022; 2022():2496649. PubMed ID: 35535356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ocular cicatricial pemphigoid. Retrospective analysis of risk factors and complications].
    Messmer EM; Hintschich CR; Partscht K; Messer G; Kampik A
    Ophthalmologe; 2000 Feb; 97(2):113-20. PubMed ID: 10734737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate therapy for ocular cicatricial pemphigoid.
    McCluskey P; Chang JH; Singh R; Wakefield D
    Ophthalmology; 2004 Apr; 111(4):796-801. PubMed ID: 15051215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular cicatricial pemphigoid, keratomycosis, and intravenous immunoglobulin therapy.
    Iaccheri B; Roque M; Fiore T; Papadaki T; Mathew B; Baltatzis S; Emara B; Tokarewicz AC; Foster CS
    Cornea; 2004 Nov; 23(8):819-22. PubMed ID: 15502484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin therapy for refractory ocular cicatricial pemphigoid: case report.
    Galdos M; Etxebarría J
    Cornea; 2008 Sep; 27(8):967-9. PubMed ID: 18724167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management and outcome of cataract surgery in ocular cicatricial pemphigoid.
    Geerling G; Dart JK
    Graefes Arch Clin Exp Ophthalmol; 2000 Feb; 238(2):112-8. PubMed ID: 10766278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study.
    Foster CS; Ahmed AR
    Ophthalmology; 1999 Nov; 106(11):2136-43. PubMed ID: 10571350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the anti-basement membrane zone antibodies in ocular and pseudo-ocular cicatricial pemphigoid.
    Bhol K; Mohimen A; Neumann R; Yunis J; Foster S; Yunis EJ; Ahmed AR
    Curr Eye Res; 1996 May; 15(5):521-32. PubMed ID: 8670753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of cataract surgery in ocular cicatricial pemphigoid.
    Puranik CJ; Murthy SI; Taneja M; Sangwan VS
    Ocul Immunol Inflamm; 2013 Dec; 21(6):449-54. PubMed ID: 23941520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.